Patent · US Active

Isolated multiple sclerosis (MS)-associated retrovirus (MSRV) nucleic acids corresponding to the gag region

US8088910B2 · kind B2 · utility

0Cited by

1References

13Claims

0Family size

Assignee

BIOMERIEUX, INC. · FR

Inventors

Glaucia Paranhos-Baccala · Val-de-Reuil, FR
Florence Komurian-Pradel · Caluire-et-Cuire, FR
Frederic Bedin · Val-de-Reuil, FR
Mireille Sodoyer · Sainte-Foy-lès-Lyon, FR
Catherine Ott · Val-de-Reuil, FR
Francois Mallet · Villeurbanne, FR
Herve Perron · Val-de-Reuil, FR
Bernard Mandrand · Villeurbanne, FR

Key dates

Filing date	May 10, 2010
Grant date	Jan 3, 2012
Priority date	—
Expiry date	May 10, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2740/10022
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

An isolated polynucleotide having a nucleotide sequence selected from the group consisting of (a) SEQ ID NO: 21, (b) the full-length sequences encoding a polypeptide having a peptide sequence selected from the group consisting of SEQ ID NOs: 25 and 26, and (c) the full-length complementary sequences to the sequences set forth in (a) or (b).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.